Deka Bank Deutsche Girozentrale Arrowhead Pharmaceuticals, Inc. Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 37,844 shares of ARWR stock, worth $717,522. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,844

Previous 36,235 4.44%

Holding current value

$717,522

Previous $927,000 20.5%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$19.36 - $29.54 $31,150 - $47,529	1,609 Added 4.44%	37,844 $737,000
Q2 2024 Aug 08, 2024	SELL	$21.87 - $28.24 $35,188 - $45,438	-1,609 Reduced 4.25%	36,235 $927,000
Q3 2023 Nov 13, 2023	BUY	$26.2 - $36.08 $74,512 - $102,611	2,844 Added 8.13%	37,844 $1.01 Million
Q1 2023 Apr 24, 2023	SELL	$23.68 - $38.51 $828,800 - $1.35 Million	-35,000 Reduced 50.0%	35,000 $847,000
Q3 2022 Nov 02, 2022	SELL	$29.63 - $48.31 $297,781 - $485,515	-10,050 Reduced 12.55%	70,000 $2.3 Million
Q2 2022 Aug 03, 2022	BUY	$27.79 - $50.61 $416,850 - $759,150	15,000 Added 23.06%	80,050 $2.72 Million
Q1 2022 Apr 28, 2022	BUY	$39.62 - $69.97 $594,300 - $1.05 Million	15,000 Added 29.97%	65,050 $2.97 Million
Q4 2021 Feb 02, 2022	BUY	$58.09 - $82.51 $360,158 - $511,562	6,200 Added 14.14%	50,050 $3.32 Million
Q3 2021 Oct 22, 2021	BUY	$58.38 - $84.96 $817,320 - $1.19 Million	14,000 Added 46.9%	43,850 $2.65 Million
Q1 2021 Apr 28, 2021	SELL	$61.35 - $90.47 $429,450 - $633,290	-7,000 Reduced 19.0%	29,850 $1.89 Million
Q4 2020 Mar 12, 2021	SELL	$43.82 - $85.37 $343,987 - $670,154	-7,850 Reduced 17.56%	36,850 $2.87 Million
Q3 2020 Oct 29, 2020	BUY	$33.21 - $51.27 $1.48 Million - $2.29 Million	44,700 New	44,700 $1.95 Million
Q3 2019 Nov 14, 2019	SELL	$26.26 - $34.86 $1.01 Million - $1.34 Million	-38,400 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$17.43 - $28.82 $1.2 Million - $1.98 Million	-68,800 Reduced 64.18%	38,400 $1.11 Million
Q1 2019 May 10, 2019	BUY	$12.05 - $20.18 $156,650 - $262,340	13,000 Added 13.8%	107,200 $1.54 Million
Q4 2018 Feb 12, 2019	SELL	$10.74 - $19.7 $139,620 - $256,100	-13,000 Reduced 12.13%	94,200 $1.13 Million
Q3 2018 Nov 09, 2018	BUY	$14.0 - $20.3 $310,800 - $450,660	22,200 Added 26.12%	107,200 $0
Q2 2018 Aug 14, 2018	BUY	$6.37 - $14.02 $541,450 - $1.19 Million	85,000 New	85,000 $1.1 Million

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Arrowhead Pharmaceuticals, Inc. Transaction History